What is the recommended management for a patient with post‑gastrectomy gastroparesis?

Management of Post-Gastrectomy Gastroparesis

For post-gastrectomy gastroparesis, initial management should focus on prokinetic medications (metoclopramide or erythromycin), with endoscopic pyloromyotomy (G-POEM) reserved for medically refractory cases, and completion gastrectomy considered only when all other interventions have failed. 1, 2

Initial Medical Management

First-Line Pharmacologic Therapy

• Metoclopramide or erythromycin are the appropriate initial pharmacologic treatments for post-gastrectomy gastroparesis 1
• These prokinetic agents should be trialed before considering any procedural interventions 1
• If standard prokinetics fail, intravenous neostigmine may provide immediate symptomatic relief in resistant cases, though this is based on limited case report evidence and requires cardiac monitoring 3

Medications to Avoid as First-Line

The following should NOT be used as initial therapy 1:

• Domperidone
• Prucalopride
• Aprepitant
• Nortriptyline
• Buspirone
• Cannabidiol

Procedural Interventions for Refractory Cases

Endoscopic Pyloromyotomy (G-POEM)

When medical therapy fails, G-POEM should be the first procedural option considered before surgical interventions 2, 1:

• Clinical success rates of 76% with significantly less perioperative morbidity compared to surgery 4
• In post-surgical gastroparesis specifically, G-POEM achieved 50% normalization of gastric emptying at follow-up 2
• Mean improvement in Gastroparesis Symptom Index Score was statistically significant (p = 0.0002) 2
• Mean operative time is only 30 minutes with minimal complications 2

Technical Requirements for G-POEM

• Submucosal tunnel created 4-5 cm proximal to the pylorus along the greater curvature or posterior wall 4
• Complete division of the pyloric ring extending 1-3 cm proximally into the antrum 4
• Full-thickness pyloromyotomy of both circular and oblique muscle bundles while preserving serosa 4

Post-Procedure Monitoring

• Follow-up at 1-3 months post-procedure 4
• Gastric emptying study no sooner than 4-8 weeks after the procedure 4
• Obtain Gastroparesis Cardinal Symptom Index (GCSI) scores before and after to quantify improvement 4

Surgical Pyloroplasty

• No specific recommendation can be made regarding surgical pyloromyotomy or pyloroplasty due to knowledge gaps 1
• However, surgical pyloroplasty shows comparable 77% clinical success rates to G-POEM but with higher perioperative morbidity 4

Definitive Surgical Management

Completion/Near-Completion Gastrectomy

This should be reserved as the last resort for carefully selected patients with documented gastroparesis who have failed all medical and endoscopic therapies 5, 6:

• Long-term symptom relief achieved in approximately 80% of patients with mean follow-up of 56 months 5
• Standardized technique uses 55-cm Roux-en-Y reconstruction 5
• No operative deaths and low complication rates in experienced centers 5, 6
• Significant improvement in severity of symptoms scores, primarily due to reduction in gastrointestinal symptoms 5, 6

Alternative Surgical Approaches

• Roux-en-Y gastric bypass may improve both symptoms and gastric emptying in refractory cases, with 87% improvement in gastric emptying reported 7
• Long-limb Roux-en-Y reconstruction after subtotal gastrectomy has shown complete resolution of symptoms in select cases 8

Important Caveats

Diagnostic Confirmation

• 4-hour gastric emptying testing is required to confirm gastroparesis; 2-hour testing should not be used 1
• Rule out mechanical obstruction with endoscopy and contrast studies before diagnosing gastroparesis 3

Gastric Electrical Stimulation

• Should NOT be used routinely as initial treatment for post-gastrectomy gastroparesis 1
• Reserved only for highly select patients with symptoms refractory to all medical therapies 1

Pitfalls to Avoid

• Do not proceed to invasive interventions without adequate trial of medical therapy 1
• Avoid breaching the serosa during pyloromyotomy procedures to prevent injury to surrounding organs 4
• Monitor for post-procedural complications including leakage, particularly if patients develop abdominal pain, tachycardia, or fever requiring CT scan or upper GI study 4